## Abstract This was an exploratory study to investigate lamivudine‐resistant hepatitis B virus (HBV) strains in selected lamivudine‐naïve HBV carriers with and without human immunodeficiency virus (HIV) co‐infection in South African patients. Thirty‐five lamivudine‐naïve HBV infected patients with
Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection
✍ Scribed by Cindy Firnhaber; Chien Yu Chen; Denise Evans; Mhairi Maskew; Doreen Schulz; Anne Reyneke; Anna Kramvis
- Book ID
- 118452181
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 220 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1201-9712
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The high frequency of mutation during hepatitis B virus (HBV) infection has resulted in 8 genotypes (A–H) with varying effects on disease severity and treatment efficacy. However, analysis of intrapatient HBV diversity is limited, especially during HIV co‐infection. Therefore, a prelimi
## Abstract HIV infection has a significant impact on the natural progression of liver disease caused by infection with hepatitis B virus (HBV), but its role in the molecular evolution of HBV is unknown. It is difficult to study the molecular evolution of HBV longitudinally considering its genomic
## Abstract Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) have similar transmission routes, implying that patients infected with HIV are at particular risk for HBV infection. Patients who are co‐infected with HIV and HBV progress more rapidly to end‐stage liver disease and differen